The Cancer Cell (CC) Formula is an experimental treatment which is currently being researched on cancer, infectious and other diseases. This technology targets cells which do not follow the Krebs metabolic cycle by delivering a lethal dose of minerals (zinc and copper) to those cells. Because cancer cells follow an anaerobic, non-Krebs metabolism, it is predicted to target cancer cells precisely. Normal, healthy cells which follow the Krebs cycle should absorb the minerals that they need and reject the rest. Because bacteria and fungi follow non-Krebs metabolic cycles, the product may also be capable of treating a variety of infections. Continue reading →
Between 5 and 10 percent of all patients contract at least one hospital-acquired infection—also known as a healthcare-associated infection or nosocomial infection—during their stay in an acute care hospital. According to estimates from the National Nosocomial Infections Surveillance (NNIS) system, in 2002, approximately 1.7 million cases of HAIs and 99,000 associated deaths occurred in U.S. hospitals, leading to extra costs of up to $6.5 billion each year. Continue reading →
Reports and agencies are releasing the newest problem in the worlds health as the number one issue facing this era “Antimicrobal Resistance”. In a consciously alarming report released by WHO, the agency said, “Without urgent action, we are heading for a post-antibiotic era, in which common infections and minor injuries can once again kill.” Continue reading →
The CC Formula can treat mutated cells, non-functioning cells, and non-typical cell diseases as well as viral, bacterial, and fungal diseases in conjunction with or without other drugs, surgery, chemotherapy, or radiation. This article lists conditions where users have reported positive results, and list additional conditions where there is a potential for application of the CC Treatment. Continue reading →
Conventional drug therapies have limitations. To break through, the medical industry is devoting time and money to cellular biology and developing treatments that effectively shut down genes tied to life-threatening diseases and genetic disorders like MRSA. Continue reading →
SARM, siglas de Staphylococcus aureus resistente. SARM es exactamente lo que su nombre dice que es, se trata de una infección por estafilococo bacteriana que tiene una resistencia a la medicación, meticilina .